In a peer-reviewed study believed to be the first of its kind published, a research team led by […]
In a new study led by Johns Hopkins Medicine, the experimental drug RK-33 has demonstrated promise in treating […]
As part of the new national Cancer AI Alliance (CAIA), scientists from the Sidney Kimmel Comprehensive Cancer Center at […]
A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help […]
By tracking the changes in prostate cancer cells over time, researchers at the Johns Hopkins Kimmel Cancer Center have […]
People with operable non-small cell lung cancers have a reduced risk of death and disease recurrence if they […]
Researchers from the Johns Hopkins Kimmel Cancer Center have found age-related changes in skin cells contribute to the […]
In a study using human breast cancer cells, scientists from the Johns Hopkins Kimmel Cancer Center have potentially […]
Researchers from the Johns Hopkins Kimmel Cancer Center have identified key markers in pancreatic cancer progession using a […]
Listen to an audio article about the new federal mandate on breast density notification. The mandate, part of […]
On September 10, 2024 the federal mandate on breast density notification takes effect. The mandate, part of the […]
A study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have identified […]
A novel test developed by Johns Hopkins Kimmel Cancer Center investigators could give gastroenterologists insight…
Using genetic engineering techniques, investigators at the Johns Hopkins Kimmel Cancer Center…
A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma, was approved…
